No insider purchase over the last 90 days. The latest, by 聂在建, was filed 19 Jul 2024.
Shandong Sanyuan Biotechnology Co.,Ltd.: what insiders have been doing
Insider filings for Shandong Sanyuan Biotechnology Co.,Ltd. are scarce in the SSE / SZSE (CSRC) feed, the latest one published on 19 July 2024. This page will fill in as new trades are disclosed. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Top signal score 15 of 100
Buys €586,744n/a Sells
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 19,723 of 26,248 companies
34.3
score / 100
Value
24
Quality
45
FCF yld-3.6%
Earn yld1.9%
EV/EBITDA46.9x
ROE2.0%
Gross mgn16%
Net mgn14%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
191,600 shares100.0% of flowA股XSHESZSE:173000007866983100
Canonical exit: 17 Oct 2024 (T+90)
1 of 1 declaration
About Shandong Sanyuan Biotechnology Co.,Ltd.
三元生物 is a company specializing in the agro-food sector, focused on the research and development of biological products. It is listed on the Shenzhen Stock Exchange (XSHE).